Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Babette Hoen

PhD student
Babette Hoen
Smart drug screening to identify a synergy between conventional chemotherapy, precision medicines and immunotherapy.

Babette Hoen graduated from Ghent University(Belgium) with a master’s degree in Biomedical Sciences, majored in oncology. Following this, she started her PhD project at the Princess Máxima Center in August 2021.

Patients with relapsed B-cell acute lymphoblastic leukemia (BCP-ALL) have a poor prognosis, and therefore especially these patients could benefit from new, innovative drug combinations. During her PhD project a drug screening will be performed to identify synergies between conventional chemotherapeutic drugs and precision medicines. An ex vivo leukemic niche will be created by co-culturing mesenchymal stromal cells and BCP-ALL cells. Additionally, immune cells will be added to this leukemic niche, which will allow including immunotherapy into the combination screening.